Advanced search
Publication Cover
Cancer Biology & Therapy Volume 20, 2019 - Issue 6
Submit an article Journal homepage
2,027
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells

Ling Maa Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;b Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, USACorrespondence[email protected]
View further author information
,
Jia Weib Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, USAView further author information
,
Gloria H. Suc Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, USAView further author information
&
Jiayuh Linb Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, USAView further author information
Pages 855-865 | Received 27 Jul 2018, Accepted 03 Feb 2019, Published online: 13 Mar 2019

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xiaofei Zhou, Yuetang Zhuang, Xiaohong Liu, Yaowen Gu, Junting Wang, Yuchen Shi, Li Zhang, Rui Li, Yelin Zhao, Hebing Chen, Jiao Li, Hongjuan Yao & Liang Li. (2023) Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 532-546.
Read now

Articles from other publishers (13)

Zahra Salmasi, Parisa Saberi-Hasanabadi, Hamidreza Mohammadi & Rezvan Yazdian-Robati. 2024. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy. Recent Advances in Nanocarriers for Pancreatic Cancer Therapy 15 34 .
Hangcheng Guo, Zujian Hu, Xuejia Yang, Ziwei Yuan, Yuanyuan Gao, Jiawei Chen, Lili Xie, Chaoyue Chen, Yangyang Guo & Yongheng Bai. (2023) STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage. International Immunopharmacology 123, pages 110709.
Crossref
Ashleigh R. Poh & Matthias Ernst. (2023) Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities. Oncogene 42:22, pages 1786-1801.
Crossref
Shaila A. Shetu, Nneoma James, Gildardo Rivera & Debasish Bandyopadhyay. (2023) Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond. Current Issues in Molecular Biology 45:3, pages 1914-1949.
Crossref
SanFei Peng & Yang Fu. (2023) FYN: emerging biological roles and potential therapeutic targets in cancer. Journal of Translational Medicine 21:1.
Crossref
Xiaoxiao Cheng, Chong Dai, Yuqi Wen, Xiaoqi Wang, Xiaochen Bo, Song He & Shaoliang Peng. (2022) NeRD: a multichannel neural network to predict cellular response of drugs by integrating multidimensional data. BMC Medicine 20:1.
Crossref
Rui-Jie Ma, Chao Ma, Kang Hu, Meng-Meng Zhao, Nan Zhang & Zhi-Gang Sun. (2022) Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review). International Journal of Oncology 61:3.
Crossref
Sevde ALTUNTAS & Kübra Nur GÖKDEMİR. (2022) Effects of FOLFIRINOX Components on Pancreatic Adenocarcinoma Cells. Adıyaman University Journal of Science.
Crossref
Lu Yang, Jiaxi Xu, Zheng Xie, Faquan Song, Xin Wang & Rupei Tang. (2021) Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo. Asian Journal of Pharmaceutical Sciences 16:6, pages 762-771.
Crossref
Hend M. Nawara, Said M. Afify, Ghmkin Hassan, Maram H. Zahra, Akimasa Seno & Masaharu Seno. (2021) Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy. Biomedicines 9:5, pages 500.
Crossref
Justin F. Creeden, Khaled Alganem, Ali S. Imami, Nicholas D. Henkel, F. Charles Brunicardi, Shi-He Liu, Rammohan Shukla, Tushar Tomar, Faris Naji & Robert E. McCullumsmith. (2020) Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia. International Journal of Molecular Sciences 21:22, pages 8823.
Crossref
Justin F. Creeden, Khaled Alganem, Ali S. Imami, F. Charles Brunicardi, Shi-He Liu, Rammohan Shukla, Tushar Tomar, Faris Naji & Robert E. McCullumsmith. (2020) Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases. International Journal of Molecular Sciences 21:22, pages 8679.
Crossref
Ka-Young Ryu, Hyun-ju Lee, Hanwoong Woo, Ri-Jin Kang, Kyung-Min Han, HyunHee Park, Sang Min Lee, Ju-Young Lee, Yoo Joo Jeong, Hyun-Wook Nam, Youngpyo Nam & Hyang-Sook Hoe. (2019) Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling. Journal of Neuroinflammation 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.